Home / Share Price Target / Brooks
Brooks Laboratories Share Price Target 2024, 2025, 2026 to 2039 With Charts
Brooks Laboratories Limited | |||
 | Symbol: BROOKS | ||
| Price: ₹138.63 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Brooks Laboratories Brief Company Overview
- 1.1: Brooks Laboratories Limited: A Renowned Pharmaceutical Company
- 1.2: Brooks Laboratories Financial Performance
- 1.2.1: Is Brooks Laboratories A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Brooks Laboratories Share Price Target For 2024
- 2.1.1: Brooks Laboratories Share Price Target Table For 2024
- 2.1.2: Summary: Brooks Laboratories Share Price Prediction For 2024
- 2.2: Brooks Laboratories Share Price Target For 2025
- 2.2.1: Brooks Laboratories Share Price Target Table For 2025
- 2.2.2: Summary: Brooks Laboratories Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Brooks Laboratories Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Brooks Laboratories Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Brooks Laboratories Past Performance
Brooks Laboratories Brief Company Overview
Brooks Laboratories Limited: A Renowned Pharmaceutical Company
Established in 2002, Brooks Laboratories Limited is a reputable pharmaceutical manufacturer based in Mumbai, India.
The company has a strong presence both domestically and internationally, specializing in a diverse range of pharmaceutical products, including:
- Liquid and dry powder injectables
- Carbapenem drugs
- Tablets
- Dry syrup
- Eye/ear drops
Brooks Laboratories Limited is committed to providing high-quality, affordable pharmaceuticals to its customers worldwide.
Brooks Laboratories Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 375.59 Crore | Market valuation of Brooks Laboratories's shares. |
| Revenue (TTM) | 81.71 Crore | Total revenue generated by Brooks Laboratories over the past twelve months. |
| Net Income (TTM) | -17.53 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | -0.68% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | -21.46% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +14.2% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio | 8.6 | Company's total debt divided by total shareholder equity. |
| Total Debt | 5.64 Crore | Sum of Brooks Laboratories's current & long-term financial obligations. |
| Total Cash | 69.34 Lakh | Total amount of liquid funds available to Brooks Laboratories. |
| Beta | 1.54 | Beta is greater than 1 indicating that the Brooks Laboratories's price is more volatile than the market. |
Is Brooks Laboratories A Good Buy For Long Term?
Brooks Laboratories, a small-cap stock with a market capitalization of ₹353.67 crore, presents a mixed outlook for long-term investment. While its 5-year return of 168.50% is impressive, the company reported a net loss of ₹17.53 crore in the last 12 months (TTM) and a negative profit margin of -21.46%. Although recent quarterly returns are positive, a low cash balance (₹69.34 lakh) against a debt of ₹5.64 crore raises concerns. Therefore, given the current financial performance, Brooks Laboratories is not a good buy for the long term. Further investigation into the reasons for the net loss is crucial before considering investment.
To predict the Brooks Laboratories's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Brooks Laboratories Share Price Target For 2024
The line chart displays the monthly closing prices of Brooks Laboratories with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Brooks Laboratories shares in 2024, see the table below.
Brooks Laboratories Share Price Target Table For 2024
| Brooks Laboratories's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 146.00 (+5.3%) | Price Action: 01 Nov 2024 High |
| 2024 Target 2 | 143.79 (+3.71%) | Custom Fibonacci Extension Lvl 82% |
| 2024 Target 1 | 142.14 (+2.52%) | Fibonacci Extension Level 123.6% |
| Current Price | 138.64 | Brooks Laboratories's 1 share price as of Thu 21 Nov 2024 |
| Stop Loss 1 | 141.16 (+1.81%) | Price Action: 17 Oct 2024 High |
| Stop Loss 2 | 139.66 (+0.73%) | Price Action: 08 Nov 2024 High |
| Stop Loss 3 | 138.09 (-0.4%) | Price Action: 22 Oct 2024 Low |
Summary: Brooks Laboratories Share Price Prediction For 2024
In summary, Brooks Laboratories has declined by ₹-4.96, recording a notable -3.45% decrease from 1st January 2024 to 21 Nov 2024. Despite the setback, our analysis of Brooks Laboratories for 2024 predicts an additional rise of 2.52% to 5.3% by the end of 2024 with three potential targets T1: 142.14, T2: 143.79, T3: 146.00. Stop Loss at SL1: 141.16, SL2: 139.66, SL3: 138.09.
Brooks Laboratories has a 52-week high of ₹185.70, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹73.25, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Brooks Laboratories.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Brooks Laboratories Share Price Target For 2025
The line chart displays the monthly closing prices of Brooks Laboratories with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Brooks Laboratories shares in 2025, see the table below.
Brooks Laboratories Share Price Target Table For 2025
| Brooks Laboratories's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 217.89 (+57.16%) | Price Action: Chart |
| 2025 Target 2 | 213.83 (+54.23%) | Price Action: Chart |
| 2025 Target 1 | 211.71 (+52.7%) | Fibonacci Extension Level 123.6% |
| Current Price | 138.64 | Brooks Laboratories's 1 share price as of Thu 21 Nov 2024 |
| Stop Loss 1 | 125.00 (-9.84%) | Price Action: 30 Oct 2024 Low |
| Stop Loss 2 | 123.30 (-11.07%) | Price Action: Aug 2024 High |
| Stop Loss 3 | 122.00 (-12.01%) | Price Action: Nov 2022 High |
Summary: Brooks Laboratories Share Price Prediction For 2025
In summary, Brooks Laboratories has declined by ₹-4.96, recording a notable -3.45% decrease from 1st January 2024 to 21 Nov 2024. Despite the setback, our analysis of Brooks Laboratories for 2025 predicts an additional rise of 52.7% to 57.16% by the end of 2025 with three potential targets T1: 211.71, T2: 213.83, T3: 217.89. Stop Loss at SL1: 125.00, SL2: 123.30, SL3: 122.00.
Brooks Laboratories has a All-Time high of ₹352.38, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹73.25, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Brooks Laboratories, we have created a specific page for that check here: Brooks Laboratories Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Brooks Laboratories Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Brooks Laboratories share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 14.74% over the next 15 years.
For complete year by year Brooks Laboratories long term share price target from 2024, 2025 to 2039 check the below table.
Brooks Laboratories Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Brooks Laboratories Target | YoY Change % |
|---|---|---|
| 2024 | ₹138.63 | [Current Price] |
| 2024 | ₹158.82 | 14.55% |
| 2025 | ₹216.39 | 36.24% |
| 2026 | ₹264.16 | 22.07% |
| 2027 | ₹374.22 | 41.66% |
| 2028 | ₹450 | 20.25% |
| 2029 | ₹504.65 | 12.14% |
| 2030 | ₹544.64 | 7.92% |
| 2031 | ₹571.58 | 4.94% |
| 2032 | ₹727.51 | 27.28% |
| 2033 | ₹807.35 | 10.97% |
| 2034 | ₹850.48 | 5.34% |
| 2035 | ₹872.88 | 2.63% |
| 2036 | ₹879.01 | 0.7% |
| 2037 | ₹1,080.8 | 22.95% |
| 2038 | ₹1,164.71 | 7.76% |
| 2039 | ₹1,088.66 | -6.53% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Brooks Laboratories Past Performance
- In 2011, Brooks Laboratories opening price was ₹18.53
- As of Thu 21 Nov 2024 the price stands at ₹138.63.
- This represents a Compound Annual Growth Rate (CAGR) of 15.46%.
- In 13 years, an investment of 10,000 would have become ₹74,819.21.
As we wrap up, we hope you like our study on Brooks Laboratories share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
